Supernus Pharmaceuticals, Inc. SUPN
NASDAQ · United States · Health Technology
$42.56-0.48 (-1.12%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 0.53 | 0.42 | +24.5% | $219.06M | +6.7% | -3.1%$44.63→$43.25 |
| Q1 2026 | 2026-05-05 | 0.45 | 0.14 | +221.4% | — | — | +5.8%$48.63→$51.45 |
| Q4 2025 | 2026-02-24 | 0.88 | 0.28 | +214.3% | — | — | +11.1%$50.69→$56.32 |
| Q3 2025 | 2025-11-04 | 0.46 | 0.33 | +39.4% | — | — | -15.4%$55.70→$47.11 |
| Q4 2024 | 2025-02-25 | 0.55 | 0.52 | +5.8% | — | — | — |
| Q3 2024 | 2024-11-04 | 1.10 | 0.44 | +150.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.